ICER, is best known as the nation’s independent watchdog on drug pricing, issues drug assessment reports include a full analysis of how well each new drug works, the economic value each treatment represents, and other elements of value that are important to patients and their families. They recently released this eye-popping study on the top drugs with large price increases that are totally unsupported by clinical effectiveness. Scripta helps you make sure your company isn’t paying too much for drugs like this.
Comments